SOURCE: Remedent, Inc.

February 20, 2014 05:49 ET

Remedent Announces Availability of Its Online Presentation as of Tuesday, February 25, 2014 at Close of Business

GENT, BELGIUM--(Marketwired - Feb 20, 2014) - Remedent, Inc. (OTCBB: REMI), an international company specializing in research, development, and manufacturing of oral care and cosmetic dentistry products, reported results for the third quarter ended December 31, 2013.

We like to mention that an online presentation will be available after the Chicago Dental Midwinter Show, which takes place from February 21 till February 23, 2014. As of Tuesday, February 25, 2014 at close of business the presentation will be accessible at our Website www.Remedent.com/investors

About Remedent
Remedent, Inc. specializes in the research, development, manufacturing and marketing of oral care and cosmetic dentistry products. The company serves professional dental industry with breakthrough technology for dental veneers. These products are supported by a line of professional veneer whitening and teeth sensitivity solutions. Headquartered in Belgium, Remedent distributes its products to more than 28 countries worldwide. For more information, go to www.remedent.com.

Forward-Looking Statements
Statements in this press release that are "forward-looking statements" are based on current expectations and assumptions that are subject to risks and uncertainties. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Remedent's actual operating results to be materially different from any historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements that explicitly describe these risks and uncertainties, readers are urged to consider statements that contain terms such as "believes," "belief," "expects," "expect," "intends," "intend," "anticipate," "anticipates," "plans," "plan," "projects," "project," to be uncertain and forward-looking. Actual results could differ materially because of factors such as Remedent's ability to achieve the synergies and value creation contemplated by the proposed transaction. For further information regarding risks and uncertainties associated with Remedent's business, please refer to the risk factors described in Remedent's filings with the Securities and Exchange Commission, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q. We undertake no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release.

Contact Information

  • For more info, please contact:
    Mr Luc Maes
    Marketing Manager
    Remedent
    Zuiderlaan 1-3 box 8, 9000 Gent - Belgium
    T: +32 (0)9-2415880
    E: info@remedent.com
    W: www.remedent.com